Skip to main content
Premium Trial:

Request an Annual Quote

Lion Cinches NetGenics Acquisition

NEW YORK, Jan. 31 - Lion Bioscience has tied up its acquisition of NetGenics, the company said on Wednesday.

The acquisition, first announced two weeks ago, makes NetGenics a part of Lion's US-based operations.


Manuel Glynias, NetGenics' president and CEO, will become senior vice president for strategic planning at Lion, and Michael Dickson, who was chief technology officer at NetGenics, will become a the senior principal architect at Lion. Both men "will initially focus on the integration of NetGenics' DiscoveryCenter software" into Lion's product portfolio, Lion said in a statement.


A spokeswoman for Lion's US headquarters, in Cambridge, Mass., said that the rest of NetGenics' employees will be spared their jobs.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.